Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer

Genomics

Volumn 45, Issue 3, 1997, Pages 607-617

  Carmeci, Charles ^a   Thompson, Devon A ^a   Ring, Huijun Z ^a   Francke, Uta ^a   Weigel, Ronald J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; BREAST CARCINOGENESIS; CHROMOSOME 7P; GENE ISOLATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

EID: 0031282001     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4972     Document Type: Article

References (53)

1. 2 dopamine receptor binding. Brain Res. 637: 163-172.
2. Benton, W. D., and Davis, R. W. (1977). Screening λgt recombinant clones by hybridization to single plaques in situ. Science 196: 180-182.
3. Biegon, A., and McEwen, B. S. (1982). Modulation by estradiol of serotonin receptors in brain. J. Neurosci. 2: 199-205.
4. Boehnke, M., Lange, K., and Cox, D. R. (1991). Statistical methods for multipoint radiation hybrid mapping. Am. J. Hum. Genet. 49: 1174-1188.
5. Bosher, J. M., Totty, N. F., Hsuan, J. J., Williams, T., and Hurst, H. (1996). A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 13: 1701-1707.
6. Bray-Ward, P., Menninger, J., Lieman, J., Desai, T., Mokady, N., Banks, A., and Ward, D. C. (1996). Integration of the cytogenetic, genetic, and physical maps of the human genome by FISH mapping of CFPH YAC clones. Genomics 32: 1-14.
7. Carmeci, C., deConinck, E. C., Lawton, T., Bloch, D. A., and Weigel, R. J. (1997). Analysis of estrogen receptor messenger RNA in breast carcinomas from archival specimins is predictive of tumor biology. Am. J. Pathol, 150: 1563-1570.
8. Chevallier, B., Heintzmann, F., Mosseri, V., Daunce, J. P., Bastit, P., Graic, Y., Brunelle, P., Basuyau, J. P., Comoz, M., and Asselain, B. (1988). Prognostic value of estrogen and progesterone receptors in operable breast cancer. Cancer 62: 2517-2524.
9. Cox, D. R., Burmeister, M., Price, E. R., Kim, S., and Myers, R. M. (1990). Radiation hybrid mapping: A somatic cell genetic method for constructing high resolution maps of mammalian chromosomes. Science 250: 245-250.
10. deConinck, E. C., McPherson, L. A., and Weigel, R. J. (1995). Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. Cell. Biol. 15: 2191-2196.
11. Dickson, R. B., Bates, S. E., McManaway, M. E., and Lippman, M. E. (1986). Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res. 46: 1707-1713.
12. Elwood, J. M., and Godolphin, W. (1980). Oestrogen receptors in breast tumours: Associations with age. Menopausal status and epidemiological and clinical features in 735 patients. Br. J. Cancer 42: 635-644.
13. Feng, Y., and Gregor, P. (1997). Cloning of a novel member of the G-protein-coupled receptor family related to peptide receptors. Biochem. Biophys. Res. Commun. 231: 651-654.
14. Fisher, E. R., Redmond, C. K., Liu, H., Reckette, H., and Fisher, B. (1980). Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 45: 349-353.
15. Fisher, E. R., Sass, R., and Fisher, B. (1987). Pathologic findings from the national surgical adjuvant breast project, correlations with concordant and discordant estrogen and progesterone receptors. Cancer 59: 1554-1559.
16. Francke, U. (1994). Digitized and differentially shaded human chromosome ideograms for genomic applications. Cytogenet. Cell Genet. 65: 206-219.
17. Francke, U., Yang-Fang, T. L., Brissenden, J. E., and Ullrich, A. (1986). Chromosomal mapping of genes involved in growth control. Cold Spring Harbor Symp. Quant. Biol. 51: 855-866.
18. Gaskell, D. J., Hawkins, R. A., Sangsterl, K., Chetty, U., and Forrest, A. P. M. (1989). Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet i: 1044-1046.
19. Higgins, D. G., Bleasby, A. J., and Fuchs, R. (1992). Improved software for multiple sequence alignment. CABIOS 8: 189-191.
20. Huff, K. K., Knabbe, C., Lindsey, R., Kaufman, D., Bronzert, D., Lippman, M. E., and Dickson, R. B. (1988). Multihormone regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol. Endocrinol. 2: 200-208.
21. Ishii, T., Yamada, M., Sato, H., Matsue, M., Taketani, S., Nakayama, K., Sugita, Y., and Bannai, S. (1993). Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268: 18633-18636.
22. Kelly, M. J., Lagrange, A. H., and Rønnekleiv, O. K. (1995). Estrogen rapidly uncouples υ-opioid receptors from potassium channels via activation of protein kinase A. Analgesia 1(4-6): 494-497.
23. Knabbe, C., Zugmaier, G., Dickson, R. B., and Lippman, M. E. (1988). Transforming growth factor β and other growth inhibitory polypeptides in human breast cancer. In "Progress in Cancer Research and Therapy - Hormones and Cancer 3: Proceedings of the Third International Congress on Hormones and Cancer" (F. Bresciani, Ed.), Vol. 35, pp. 234-237, Raven Press, New York.
24. Knight, W. A., III, Livingston, R. B., Gregory, E. J., and McGuire, W. L. (1977). Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 37: 4669-4671.
25. Kuang, W. W., Thompson, D.A., Hoch, R.V., and Weigel, R. J. (1997). Suppression subtractive hybridization identifies genes expressed in hormone-responsive breast carcinomas. [Submitted for publication]
26. Kyte, J., and Doolittle, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
27. Lagrange, A. H., Ronnekleiv, O. K., and Kelly, M. J. (1994). The potency of mu-opiod hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17 beta-estradiol. J. Neurosci. 14: 6196-6204.
28. Lee, T. H., Lee, G. W., Ziff, E. B., and Vilcek, J. (1990). Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol. Cell. Biol. 10: 1982-1988.
29. Lesser, M., Rosen, P. P., Senie, R., Duthie, K., Menendez-Bolet, C. J., and Schwartz, M. K. (1981). Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology. Cancer 48: 299-309.
30. Li, L., Li, X., Francke, U., and Cohen, S. N. (1997). The TSG101 tumor susceptibility gene is located in chromosome 11, band p15 and is mutated in human breast cancer. Cell 88: 143-154.
31. Li, M., and Schweitzer, H. P. (1993). Resolution of common DNA sequencing ambiguities of GC-rich DNA templates by terminal deoxynucleotidyl transferase. In "Focus" (D. Cupo, Ed.), Vol. 15, pp. 19-20, Life Technologies, Gaithersburg, MD.
32. Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P. (1982). Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line. Nucleic Acids Res. 10: 7895-7903.
33. Mason, B. H., Holdaway, T. M., Mullins, P. R., Yee, L. H., and Kay, R. G. (1983). Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res. 43: 2985-2990.
34. May, F. E. B., Johnson, M. D., Weisman, L. R., Wakeling, A. E., Kastner, P., and Westley, B. R. (1989). Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines. J. Steroid Biochem. 33: 1035-1041.
35. May, F. E. B., and Westley, B. R. (1988). Identification and characterization of estrogen-regulated RNAs in human breast cancer cells. J. Biol. Chem. 263: 12901-12908.
36. McPherson, L. A., Baichwal, V. R., and Weigel, R. J. (1997). Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. USA 94: 4342-4347.
37. Miller, W. R. (1996). Mechanism of estrogen action. In "Estrogen and Breast Cancer," pp. 111-123, R. G. Landes and Chapman & Hall, Austin, TX.
38. Mohn, K. L., Laz, T. M., Melby, A. E., and Taub, R. (1990). Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. J. Biol. Chem. 265: 21914-21921.
39. Mount, S. M. (1982). A catalogue of splice junction sequences. Nucleic Acids Res. 10: 459-472.
40. Owman, C., Blay, P., Nilsson, C., and Lolait, S. (1996). Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem. Biophys. Res. Commun. 228: 285-292.
41. Pandis, N., Yuesheng, J., Gorunova, L., Petersson, C., Bardi, G., Idvall, I., Johansson, B., Ingvar, C., Mandahl, N., Mitelman, F., and Heim, S. (1995). Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosomes Cancer 12: 173-175.
42. Prestridge, D. S. (1991). SIGNAL SCAN: A computer program that scans DNA sequences for the eukaryotic transcriptional elements. CABIOS 7: 203-206.
43. Rio, M. C., Bellocq, J. P., Geirard, B., Rasmussen, U. B., Krust, A., Koehl, C., Calderoli, H., Schiff, V., Renaud, R., and Chambon, P. (1987). Specific expression of pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ErbB2. Proc. Natl. Acad Sci. USA 84: 9243-9247.
44. Salomon, D. S., Kidwell, W. R., Kim, N., Ciardiello, F., Bates, S. E., Valverius, E., Lippman, M. E., Dickson, R. B., and Stampfer, M. (1989). Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells. Recent Results Cancer Res. 113: 57-69.
45. Shenker, A. (1995). G protein-coupled receptor structure and function: The impact of disease causing mutations. Bailliére's Clin. Endocrinol. Metab. 9: 427-451.
46. Sommers, C. L., Walker-Jones, D., Heckford, S. E., Worland, P., Valverius, E., Clark, R., McCormick, F., Stampfer, M., Abularach, S., and Gelmann, P. (1989). Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res. 49: 4258-4263.
47. Strader, C. D., Fong, T. M., Tota, M. R., and Underwood, D. (1994). Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63: 101-132.
48. Swain, S. L., and Lippman, M. E. (1986). Anchorage independent epithelial colony stimulating activity in human breast cancer cell lines. Proc. Annu. Meeting Am. Assoc. Cancer Res. 27: Abstract 844.
49. Tang, Z., Treilleux, I., and Brown, M. (1997). A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers. Mol. Cell. Biol. 17: 1274-1280.
50. van der Burg, B., Slager-Davidov, R., van der Leede, B. M., de Laat, S. W., and van der Saag, P. T. (1995). Differential regulation of AP1 activity by retinoic acid in hormone-dependent and -independent breast cancer cells. Mol. Cell. Endocrinol. 112: 143-152.
51. Walter, M. A., Spillet, D. J., Thomas, P., Weissenbach, J., and Good-fellow, P. N. (1994). A method for constructing radiation hybrid maps of whole genomes. Nature Genet. 7: 22-28.
52. Weigel, R. J., and Nevins, J. R. (1990). Adenovirus infection of differentiated F9 cells results in a global shut-off of differentiation-induced gene expression. Nucleic Acids Res. 18: 6107-6112.
53. Williamson, J. A., Bosher, J. M., Skinner, A., Sheer, D., Williams, T., and Hurst, H. C. (1996). Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics 35: 262-264.